Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface (VSX) Global Registry

NCT04907240 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT04907240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface (VSX) Global Registry
Lead sponsor
W.L.Gore & Associates
Phase
Observational
Overall status
Active, not recruiting
Start date
October 9, 2021
Completion date
October 31, 2035
Enrollment
614 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis access, peripheral artery disease, popliteal aneurysm, trauma injury, visceral artery aneurysms